LYNNE KOJAMANIAN: Open Payments
NPI 1780111948 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $254 |
| ABBVIE INC. | 1 | $124 |
| Lilly USA, LLC | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REZDIFFRA, QULIPTA, MOUNJARO, OFEV, KISUNLA, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
